ALKS logo

Alkermes plc (ALKS) Accounts Receivable

Annual Accounts Receivable:

$389.52M+$56.34M(+16.91%)
December 31, 2024

Summary

  • As of today, ALKS annual accounts receivable is $389.52 million, with the most recent change of +$56.34 million (+16.91%) on December 31, 2024.
  • During the last 3 years, ALKS annual accounts receivable has risen by +$62.96 million (+19.28%).
  • ALKS annual accounts receivable is now at all-time high.

Performance

1-Year Change

+16.91%

3-Year Change

+19.28%

5-Year Change

+46.73%

15-Year Change

+66.75%

ALKS Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

84.96%
ALKS annual accounts receivable is higher than 84.96% of companies in Healthcare sector

Range

All-Time High

$389.52M
ALKS annual accounts receivable is currently at an all-time high

3-Year Low

$296.90M
ALKS annual accounts receivable is currently +31.20% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ALKS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ALKS next annual earnings announcement has not yet been scheduled

OtherALKSbalance sheet metrics

Annual Accounts Payable

$45.63M
ALKS annual accounts payable is $45.63 million

Annual Total Assets

$2.06B
ALKS annual total assets is $2.06 billion

Annual Total Liabilities

$590.59M
ALKS annual total liabilities is $590.59 million

Annual Cash & Cash Equivalents

$751.67M
ALKS annual cash & cash equivalents is $751.67 million

Quarterly Accounts Receivable:

$356.33M+$34.58M(+10.75%)
June 30, 2025

Summary

  • As of today, ALKS quarterly accounts receivable is $356.33 million, with the most recent change of +$34.58 million (+10.75%) on June 30, 2025.
  • Over the past year, ALKS quarterly accounts receivable has dropped by -$13.58 million (-3.67%).
  • ALKS quarterly accounts receivable is now -8.52% below its all-time high of $389.52 million, reached on December 31, 2024.

Performance

3-Month Change

+10.75%

1-Year Change

-3.67%

3-Year Change

+35.83%

5-Year Change

+44.48%

ALKS Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

83.75%
ALKS quarterly accounts receivable is higher than 83.75% of companies in Healthcare sector

Range

All-Time High

$389.52M
ALKS quarterly accounts receivable is currently -8.52% below its historical high of $389.52 million

3-Year Low

$267.28M
ALKS quarterly accounts receivable is currently +33.32% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
ALKS previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 23, 2025
ALKS next earnings announcement is scheduled for Oct 23, 2025

OtherALKSbalance sheet metrics

Quarterly Accounts Payable

$99.21M
ALKS quarterly accounts payable is $99.21 million

Quarterly Total Assets

$2.25B
ALKS quarterly total assets is $2.25 billion

Quarterly Total Liabilities

$628.23M
ALKS quarterly total liabilities is $628.23 million

Quarterly Cash & Cash Equivalents

$1.02B
ALKS quarterly cash & cash equivalents is $1.02 billion

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

ALKS Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+16.9%-3.7%
3Y3 Years+19.3%+35.8%
5Y5 Years+46.7%+44.5%

ALKS Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+31.2%-8.5%+33.3%
5Y5-Yearat high+46.7%-8.5%+41.0%
All-TimeAll-Timeat high>+9999.0%-8.5%>+9999.0%

ALKS Accounts Receivable History

DateAnnualQuarterly
Jun 2025
-
$356.33M(+10.7%)
Mar 2025
-
$321.75M(-17.4%)
Dec 2024
$389.52M(+16.9%)
$389.52M(+5.2%)
Sep 2024
-
$370.18M(+0.1%)
Jun 2024
-
$369.91M(+16.7%)
Mar 2024
-
$317.08M(-4.8%)
Dec 2023
$333.18M(+12.2%)
$333.18M(-2.1%)
Sep 2023
-
$340.46M(+1.8%)
Jun 2023
-
$334.48M(+20.5%)
Mar 2023
-
$277.61M(-6.5%)
Dec 2022
$296.90M(-9.1%)
$296.90M(+11.1%)
Sep 2022
-
$267.28M(+1.9%)
Jun 2022
-
$262.33M(-2.9%)
Mar 2022
-
$270.15M(-17.3%)
Dec 2021
$326.56M(+12.8%)
$326.56M(+11.6%)
Sep 2021
-
$292.67M(-4.4%)
Jun 2021
-
$306.15M(+21.1%)
Mar 2021
-
$252.79M(-12.7%)
Dec 2020
$289.54M(+9.1%)
$289.54M(+3.4%)
Sep 2020
-
$280.04M(+13.5%)
Jun 2020
-
$246.63M(-5.5%)
Mar 2020
-
$260.92M(-1.7%)
Dec 2019
$265.47M(-11.6%)
$265.47M(+4.0%)
Sep 2019
-
$255.26M(-6.8%)
Jun 2019
-
$273.92M(+18.4%)
Mar 2019
-
$231.26M(-20.9%)
Dec 2018
$300.45M(+28.6%)
$292.22M(+10.5%)
Sep 2018
-
$264.39M(-2.0%)
Jun 2018
-
$269.81M(+12.3%)
Mar 2018
-
$240.23M(+2.8%)
Dec 2017
$233.59M(+22.2%)
$233.59M(+12.6%)
Sep 2017
-
$207.54M(+3.9%)
Jun 2017
-
$199.71M(+13.2%)
Mar 2017
-
$176.49M(-7.6%)
Dec 2016
$191.10M(+22.9%)
$191.10M(+7.7%)
Sep 2016
-
$177.45M(-4.1%)
Jun 2016
-
$185.01M(+32.3%)
Mar 2016
-
$139.81M(-10.1%)
Dec 2015
$155.49M(+2.6%)
$155.49M(+10.3%)
Sep 2015
-
$140.99M(+3.8%)
Jun 2015
-
$135.78M(-4.4%)
Mar 2015
-
$141.98M(-6.3%)
Dec 2014
$151.55M
$151.55M(+5.5%)
Sep 2014
-
$143.69M(+3.1%)
Jun 2014
-
$139.32M(+13.1%)
DateAnnualQuarterly
Mar 2014
-
$123.15M(-8.2%)
Dec 2013
$134.15M(+39.2%)
$134.15M(+11.4%)
Sep 2013
-
$120.45M(+25.0%)
Mar 2012
$96.38M(+319.6%)
$96.38M(-7.9%)
Dec 2011
-
$104.68M(+31.4%)
Sep 2011
-
$79.64M(+130.3%)
Jun 2011
-
$34.58M(+50.6%)
Mar 2011
$22.97M(-9.3%)
$22.97M(-5.0%)
Dec 2010
-
$24.17M(-32.4%)
Sep 2010
-
$35.77M(+47.4%)
Jun 2010
-
$24.27M(-4.1%)
Mar 2010
$25.32M(+3.0%)
$25.32M(-10.3%)
Dec 2009
-
$28.23M(-16.2%)
Sep 2009
-
$33.70M(+20.8%)
Jun 2009
-
$27.90M(+13.5%)
Mar 2009
$24.59M(-48.0%)
$24.59M(-8.0%)
Dec 2008
-
$26.71M(-25.9%)
Sep 2008
-
$36.05M(+13.7%)
Jun 2008
-
$31.70M(-32.9%)
Mar 2008
$47.25M(-15.7%)
$47.25M(+17.4%)
Dec 2007
-
$40.26M(-8.3%)
Sep 2007
-
$43.88M(-34.3%)
Jun 2007
-
$66.78M(+19.1%)
Mar 2007
$56.05M(+40.8%)
$56.05M(-10.2%)
Dec 2006
-
$62.38M(-3.0%)
Sep 2006
-
$64.28M(+55.5%)
Jun 2006
-
$41.35M(+3.9%)
Mar 2006
$39.80M(+111.5%)
$39.80M(+19.1%)
Dec 2005
-
$33.41M(+40.1%)
Sep 2005
-
$23.85M(-14.3%)
Jun 2005
-
$27.82M(+47.9%)
Mar 2005
$18.82M(+63.2%)
$18.82M(+104.2%)
Mar 2004
$11.53M(+57.9%)
-
Dec 2003
-
$9.21M(-52.0%)
Mar 2003
$7.30M(-61.7%)
-
Mar 2002
$19.04M(+73.8%)
-
Dec 2001
-
$19.19M(-6.0%)
Sep 2001
-
$20.42M(-36.6%)
Mar 2001
$10.95M(+244.1%)
-
Dec 2000
-
$32.22M(+4.5%)
Sep 2000
-
$30.85M(+0.8%)
Jun 2000
-
$30.60M(+861.5%)
Mar 2000
$3.18M
$3.18M(-78.0%)
Sep 1997
-
$14.48M(+329.8%)
Dec 1996
-
$3.37M

FAQ

  • What is Alkermes plc annual accounts receivable?
  • What is the all-time high annual accounts receivable for Alkermes plc?
  • What is Alkermes plc annual accounts receivable year-on-year change?
  • What is Alkermes plc quarterly accounts receivable?
  • What is the all-time high quarterly accounts receivable for Alkermes plc?
  • What is Alkermes plc quarterly accounts receivable year-on-year change?

What is Alkermes plc annual accounts receivable?

The current annual accounts receivable of ALKS is $389.52M

What is the all-time high annual accounts receivable for Alkermes plc?

Alkermes plc all-time high annual accounts receivable is $389.52M

What is Alkermes plc annual accounts receivable year-on-year change?

Over the past year, ALKS annual accounts receivable has changed by +$56.34M (+16.91%)

What is Alkermes plc quarterly accounts receivable?

The current quarterly accounts receivable of ALKS is $356.33M

What is the all-time high quarterly accounts receivable for Alkermes plc?

Alkermes plc all-time high quarterly accounts receivable is $389.52M

What is Alkermes plc quarterly accounts receivable year-on-year change?

Over the past year, ALKS quarterly accounts receivable has changed by -$13.58M (-3.67%)
On this page